Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer

Radiotherapy and Oncology

Volumn 55, Issue 3, 2000, Pages 241-249

  Zelefsky, Michael J ^a   Fuks, Zvi ^a   Happersett, Laura ^a   Lee, Henry J ^a   Ling, C Clifton ^a   Burman, Chandra M ^a   Hunt, Margie ^a   Wolfe, Theresa ^a   Venkatraman, E S ^a   Jackson, Andrew ^a   Skwarchuk, Mark ^a   Leibel, Steven A ^a  

^a Mem Sloan Kettering Cancer C ^*  (United States)

Author keywords

Acute toxicity; Intensity modulated radiation therapy; Inverse treatment planning; Late toxicity; Prostate cancer; Three dimensional conformal radiation therapy

Indexed keywords

ANDROGEN; BICALUTAMIDE; LEUPRORELIN;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HISTOGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION DOSE DISTRIBUTION; RADIATION RESPONSE; RATING SCALE; RECTUM HEMORRHAGE; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; SAFETY;

EID: 0034212772     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(99)00100-0     Document Type: Article

References (57)

1. American Joint Committee on Cancer. Manual for Staging of Cancer. Beahrs O.H., Henson D.E., Hutter R.V.P., Kennedy B.J. Prostate. 5th ed :1998;J.B. Lippincott, Philadelphia, PA.
2. Balter J.M., Sandler H.M., Lam K., Bree R.L., Lichter A.S., Ten Haken R.K. Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int. J. Radiat. Oncol. Biol. Phys. 31:1995;113-118.
3. Beard C.J., Kijewski P., Bussiere M., et al. Analysis of prostate and seminal vesicle motion: Implications for treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 34:1996;451-458.
4. Boersma L.J., van den Brink M., Bruce A.M., Shouman T., Gras L., te Velde A., Lebesque J.V. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer using dose-volume histograms. Int. J. Radiat. Oncol. Biol. Phys. 41:1998;83-92.
5. Bortfeld T., Burkelbach B., Boesecke R., Schiegel W. Three-dimensional solution of the inverse problem in conformation radiotherapy. Breit A. Advanced radiation therapy: Tumor response monitoring and treatment planning. 1992;503-508 Springer Verlag, Berlin.
6. Bortfeld T., Burkelbach J., Boesecke R., Schiegel W. Methods of image reconstruction from projections applied to conformation radiotherapy. Phys. Med. Biol. 35:1990;1423-1434.
7. Bortfeld T., Kahler D.L., Waldron T.S., Boyer A.L. X-ray field compensation with multileaf collimators. Int. J. Radiat. Oncol. Biol. Phys. 28:1994;72-73.
8. Boyer A.L., Geis P., Grant W., Carol M. Modulated beam conformal radiotherapy for head and neck tumors. Int. J. Radiat. Oncol. Biol. Phys. 39:1997;227-236.
9. Brahme A. Optimization of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 28:1994;785-787.
10. Brahme A. Optimization of stationary and moving beam radiation therapy techniques. Radiat. Oncol. 12:1988;129-140.
11. Burman C., Chui C., Kutcher G., et al. Planning, delivery and quality assurance of intensity modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 39:1997;863-873.
12. Convery D.S., Rosenbloom M.E. The generation of intensity-modulated fields for conformal radiotherapy by dynamic collimation. Phys. Med. Biol. 37:1992;1359-1374.
13. Dearnaley D.P., Khoo V.S., Norman A.R., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet. 353:1999;267-272.
14. Galvin J.M., Smith A.R., Lally B. Characterization of a multi-leaf collimator system. Int. J. Radiat. Oncol. Biol. Phys. 25:1993;181-192.
15. Galvin J.M., Xuan-Gen C., Smith R.M. Combining multileaf fields to modulate fluence distributions. Int. J. Radiat. Oncol. Biol. Phys. 27:1993;697-705.
16. Goitein M. The inverse problem. Int. J. Radiat. Oncol. Biol. Phys. 18:1990;488-491.
17. Hanks G.E., Lee W.R., Hanlon A.L., et al. Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen >10 ng/ml. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;862-868.
18. Hanley J., Lumley M.A., Mageras G.S., et al. Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate. Int. J. Radiol. Oncol. Biol. Phys. 37:1997;435-444.
19. Hendry J.H., Moore J.V. Is the steepness of dose-incidence curves for tumour control or complications due to variation before or as a result of irradiation? Br. J. Radiol. 57:1984;1045-1046.
20. Hettmansperger J.P. Statistical inference based on ranks. 1984;Wiley, New York. pp. 31-38.
21. Holmes T., Mackie T.R. A filtered backprojection dose calculation method for inverse treatment planning. Med. Phys. 21:1993;303-313.
22. Jackson A., Wang X.H., Mohan R. Optimization of conformal treatment planning and quadratic dose objectives. Med. Phys. 21:1994;1006.
23. Jackson A., Zelefsky M., Cowan D., et al. Rectal bleeding after conformal radiotherapy of prostate cancer and dose volume histograms. Int. J. Radiat. Oncol. Biol. Phys. 42:1998;217.
24. Kallman P., Lind B.K., Brahme A. An algorithm for maximizing the probability of complication-free tumor control in radiation therapy. Phys. Med. Biol. 37:1992;871-890.
25. Kaplan E.L., Meier P. Non-parametic estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-816.
26. Lawton C.A., Won M., Pilepich M.V., et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;935-936.
27. Lee W.R., Hanks G.E., Hanlon A., Schultheiss T.E., Hunt M.A. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;251-257.
28. Leibel S.A., Zelefsky M.J., Kutcher G.J., et al. The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. Semin. Oncol. 21:1994;580-597.
29. Ling C.C., Burman C., Chui C.S., et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with multileaf collimation. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;721-730.
30. Mageras G.S., Mohan R. Application of fast simulated annealing to optimization of conformal radiation treatments. Med. Phys. 20:1993;447-639.
31. Mantel N. Evaluation of survival data and two rank order statistics-consideration. Cancer Chemo. Rep. 50:1966;163-170.
32. Mohan R., Wang X., Jackson A., et al. The potential and limitations of the inverse radiotherapy technique. Radiat. Oncol. 32:1994;232-248.
33. Munro T.R., Gilbert C.W. The relation between tumour lethal doses and the radiosensitivity of tumour cells. Br. J. Radiol. 34:1961;246-250.
34. Pollack A., Zagars G.K. External beam radiotherapy dose-response of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 39:1997;1011-1018.
35. Porter E.H. The statistical dose-cure relationships for irradiated tumors. Br. J. Radiol. 53:1980;336-345.
36. Roach M. III, Picket B., Rosenthal S.A., Verhey L., Phillips T.L. Defining treatment margins for six field conformal irradiation of localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 28:1996;267-275.
37. Roach M. III, Meehan S., Kroll S., et al. Radiotherapy for high grade clinically localized adenocarcinoma of the prostate. J. Urol. 156:1996;1719-1723.
38. Roeske J.C., Forman J.D., Mesina C.F., et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder and rectum during a course of external beam radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;1321-1329.
39. Rudat V., Schraube P., Oetzel D., Zierhut D., Flentje M., Wannenmacher M. Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 35:1999;1027-1034.
40. Schild S.E., Casale H.E., Bellefontaine L.P. Movements of the prostate due to rectal and bladder distention: implications for radiotherapy. Med. Dosim. 18:1993;13-15.
41. Shipley W.U., Verhey L.J., Munzenrider J.E., et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;3-12.
42. Soderstrom S., Gustafsson A., Brahme A. Optimization of the dose delivery in few field techniques using radiobiological objective functions. Med. Phys. 20:1993;1201-1210.
43. Spirou S.V., Chui C.S. Generation of arbitrary fluence profiles by dynamic jaws or multileaf collimators. Med. Phys. 21:1994;1031-1041.
44. Thames H.D., Schultheiss T.E., Hendry J.H., Tucker S.L., Dubray B.M., Brock W.A. Can modest escalations of dose be detected as increased tumor control. Int. J. Radiat. Oncol. Biol. Phys. 22:1994;241-246.
45. van Herk M., Bruce A., Kroes A.P.G., Shouman T., Touw A., Lebesque J.V. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional (3D) image registration. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;1311-1320.
46. Wang X.H., Mohan R., Jackson A., Leibel S.A., Fuks Z., Ling C.C. Optimization of intensity modulated 3D conformal treatment plans based on biological indices. Radiat. Oncol. 37:1995;87-180.
47. Webb S. Optimization by simulated annealing of three-dimensional conformal treatment planning for radiation fields defined by multi-leaf collimator: II. Inclusion of two-dimensional modulation of X-ray intensity. Phys. Med. Biol. 37:1992;1689-1704.
48. Zagars G.K., Schultheiss T.E., Peters L.P. Inter-tumor heterogeneity and radiation dose control curves. Radiat. Oncol. 8:1987;353-362.
49. Zelefsky M.J., Leibel S.A., Kutcher G.J., Fuks Z. Three -dimensional conformal radiotherapy and dose escalation: where do we stand? Semin. Radiat. Oncol. 8:1998;107-114.
50. Zelefsky M.J., Happersett L., Leibel S.A., et al. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;13-19.
51. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 41:1998;491-500.
52. Zelefsky M.J., Crean D., Mageras G.S., et al. Quantification and predictors of prostate position variability in fifty patients evaluated with multiple CT scans during conformal radiotherapy. Rad. Oncol. 50:1999;225-234.
53. Zelefsky M.J., Fuks Z., Wolfe T., Kutcher G.J., Burman C., Ling C.C., Venkatraman E.S., Leibel S.A. Locally advanced prostate cancer: long-term toxicity outcome after three dimensional conformal radiotherapy- a dose escalation study. Radiology. 209:1998;169-174.
54. Zelefsky M.J., Happersett L., Leibel S.A., et al. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. Int. J. Rad. Oncol. Biol. Phys. 37:1997;13-19.
55. Zelefsky M.J., Leibel S.A., Burman C.M., et al. Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy. Int. J. Rad. Oncol. Biol. Phys. 29:1994;755-761.
56. Zelefsky M.J., Aschkenasy E., Leibel S.A., Kelson S., Fuks Z. Tolerance and early outcome results of post-prostatectomy three dimensional conformal radiotherapy. Int. J. Rad. Oncol. Biol. Phys. 39:1997;327-333.
57. Zelefsky M.J., Leibel S.A., Fuks Z. In response to Drs Vincini, Ziaja and Martinez. Int. J. Rad. Oncol. Biol. Phys. 43:1999;235-236.